Revenues of MADRIGAL PHARMACEUTICALS, INC. from 31 Dec 2012 to 31 Mar 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
- Summary
-
MADRIGAL PHARMACEUTICALS, INC. quarterly and annual Revenues in USD history and change rate from 31 Dec 2012 to 31 Mar 2025.
- MADRIGAL PHARMACEUTICALS, INC. Revenues for the quarter ending 31 Mar 2025 was $137,250,000.
- MADRIGAL PHARMACEUTICALS, INC. annual Revenues for 2024 was $180,133,000.
- MADRIGAL PHARMACEUTICALS, INC. annual Revenues for 2023 was $0.
- MADRIGAL PHARMACEUTICALS, INC. annual Revenues for 2022 was $0.
- Source SEC data
- View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, Annual (USD)
MADRIGAL PHARMACEUTICALS, INC. Quarterly Revenues (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2025 | $137,250,000 | +$137,250,000 | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 01 May 2025 | 2025 | Q1 | ||
| Q1 2024 | $0 | $0 | $0 | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 01 May 2025 | 2025 | Q1 | |
| Q4 2023 | $0 | $0 | $0 | 01 Oct 2023 | 31 Dec 2023 | 10-K | 28 Feb 2024 | 2023 | FY | |
| Q3 2023 | $0 | $0 | $0 | 01 Jul 2023 | 30 Sep 2023 | 10-K | 28 Feb 2024 | 2023 | FY | |
| Q2 2023 | $0 | $0 | $0 | 01 Apr 2023 | 30 Jun 2023 | 10-K | 28 Feb 2024 | 2023 | FY | |
| Q1 2023 | $0 | $0 | $0 | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 07 May 2024 | 2024 | Q1 | |
| Q4 2022 | $0 | $0 | $0 | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Feb 2024 | 2023 | FY | |
| Q3 2022 | $0 | $0 | $0 | 01 Jul 2022 | 30 Sep 2022 | 10-K | 28 Feb 2024 | 2023 | FY | |
| Q2 2022 | $0 | $0 | $0 | 01 Apr 2022 | 30 Jun 2022 | 10-K | 28 Feb 2024 | 2023 | FY | |
| Q1 2022 | $0 | $0 | $0 | 01 Jan 2022 | 31 Mar 2022 | 10-K | 28 Feb 2024 | 2023 | FY | |
| Q4 2021 | $0 | $0 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 28 Feb 2024 | 2023 | FY | ||
| Q3 2021 | $0 | $0 | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 04 Nov 2021 | 2021 | Q3 | ||
| Q2 2021 | $0 | $0 | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 05 Aug 2021 | 2021 | Q2 | ||
| Q1 2021 | $0 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 06 May 2021 | 2021 | Q1 | |||
| Q3 2020 | $0 | $0 | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 04 Nov 2021 | 2021 | Q3 | ||
| Q2 2020 | $0 | $0 | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 05 Aug 2021 | 2021 | Q2 | ||
| Q3 2019 | $0 | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 05 Nov 2020 | 2020 | Q3 | |||
| Q2 2019 | $0 | 01 Apr 2019 | 30 Jun 2019 | 10-Q | 06 Aug 2020 | 2020 | Q2 |
MADRIGAL PHARMACEUTICALS, INC. Annual Revenues (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | $180,133,000 | +$180,133,000 | 01 Jan 2024 | 31 Dec 2024 | 10-K | 26 Feb 2025 | 2024 | FY | |
| 2023 | $0 | $0 | 01 Jan 2023 | 31 Dec 2023 | 10-K | 26 Feb 2025 | 2024 | FY | |
| 2022 | $0 | $0 | 01 Jan 2022 | 31 Dec 2022 | 10-K | 26 Feb 2025 | 2024 | FY | |
| 2021 | $0 | $0 | 01 Jan 2021 | 31 Dec 2021 | 10-K | 28 Feb 2024 | 2023 | FY | |
| 2020 | $0 | $0 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 24 Feb 2022 | 2021 | FY | |
| 2019 | $0 | 01 Jan 2019 | 31 Dec 2019 | 10-K | 24 Feb 2022 | 2021 | FY | ||
| 2012 | $147,000 | 01 Jan 2012 | 31 Dec 2012 | 10-K | 12 Mar 2015 | 2014 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.